scholarly article | Q13442814 |
P50 | author | Emily Chew | Q24266614 |
Amitha Domalpally | Q42716579 | ||
Elvira Agrón | Q83234331 | ||
Traci E Clemons | Q92993074 | ||
Age-Related Eye Disease Study 2 Research Group | Q117242065 | ||
Ronald P Danis | Q117242070 | ||
P2093 | author name string | Barbara Blodi | |
P2860 | cites work | Global data on visual impairment in the year 2002 | Q24650312 |
Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO). | Q24799845 | ||
Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration | Q30728578 | ||
Designing clinical trials for age-related geographic atrophy of the macula: enrollment data from the geographic atrophy natural history study | Q31099429 | ||
Issues in quantifying atrophic macular disease using retinal autofluorescence | Q33249400 | ||
Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration | Q33269883 | ||
Evaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophy | Q33339189 | ||
Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. | Q33502975 | ||
The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. | Q33774150 | ||
Use of fundus autofluorescence images to predict geographic atrophy progression | Q34580441 | ||
Fundus autofluorescence imaging in age-related macular degeneration | Q34952682 | ||
Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial | Q34956193 | ||
Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degeneration | Q35145864 | ||
Comparison of Geographic Atrophy Growth Rates Using Different Imaging Modalities in the COMPLETE Study | Q35630746 | ||
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | Q36360812 | ||
Scanning laser ophthalmoscopic analysis of the pattern of visual loss in age-related geographic atrophy of the macula | Q36677313 | ||
Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease | Q36823629 | ||
Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity | Q36886079 | ||
The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials | Q36924781 | ||
Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area | Q36968738 | ||
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2) | Q36996217 | ||
The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study | Q37033918 | ||
Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration | Q37314763 | ||
Fundus autofluorescence and progression of age-related macular degeneration | Q37378156 | ||
Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study). | Q38945380 | ||
Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2. | Q39843458 | ||
Concordance of disease progression in bilateral geographic atrophy due to AMD. | Q39902539 | ||
The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. | Q43796210 | ||
Geographic atrophy of the retinal pigment epithelium | Q44824754 | ||
Multimodal evaluation of foveal sparing in patients with geographicatrophy due to age-related macular degeneration | Q45167302 | ||
Measuring geographic atrophy in advanced age-related macular degeneration. | Q51386893 | ||
In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics | Q72631037 | ||
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope | Q73089239 | ||
Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration | Q78257646 | ||
P433 | issue | 11 | |
P921 | main subject | eye disease | Q3041498 |
geographic atrophy | Q47200750 | ||
P304 | page(s) | 2401-2407 | |
P577 | publication date | 2016-07-19 | |
P1433 | published in | Ophthalmology | Q7098109 |
P1476 | title | Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11. | |
P478 | volume | 123 |
Q90082786 | Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15 |
Q89000394 | Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy |
Q49488840 | MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION. |
Q41697555 | MMP-2 Rs24386 (C-->T) gene polymorphism and the phenotype of age-related macular degeneration |
Q56243532 | Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16 |
Q92589150 | Semi-automated quantification of geographic atrophy with blue-light autofluorescence and spectral-domain optical coherence tomography: a comparison between the region finder and the advanced retinal pigment epithelium tool in the clinical setting |
Q94400988 | Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age‐related macular degeneration |
Search more.